Cargando…
Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States
BACKGROUND: von Willebrand disease (VWD) can lead to serious, life-threatening bleeding events associated with substantial clinical and economic burden. OBJECTIVE: To estimate the prevalence, health care resource utilization (HCRU), and costs associated with major bleeding events in patients with VW...
Autores principales: | Lu, Mei, Oladapo, Abiola, Wu, Yanyu, Farahbakhshian, Sepehr, Ewenstein, Bruce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394209/ https://www.ncbi.nlm.nih.gov/pubmed/33307935 http://dx.doi.org/10.18553/jmcp.2020.20327 |
Ejemplares similares
-
Economic Burden Associated with Major Surgery in Patients with von Willebrand Disease: A United States Retrospective Administrative Database Analysis
por: Oladapo, Abiola, et al.
Publicado: (2021) -
Bleeding patterns in patients before and after diagnosis of von Willebrand disease: Analysis of a US medical claims database
por: Roberts, Jonathan C., et al.
Publicado: (2021) -
Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
por: Gritsch, Herbert, et al.
Publicado: (2022) -
ADAMTS‐13 and bleeding phenotype in von Willebrand disease
por: Boender, Johan, et al.
Publicado: (2020) -
Diagnosis and Treatment of von Willebrand Disease and Rare Bleeding Disorders
por: Castaman, Giancarlo, et al.
Publicado: (2017)